VKTX Company Profile and Key Details

Q: Who are the executives of VKTX?

Mr. Michael MorneauVice President of Fin. & Admin.Dr. Brian Lian Ph.D.Pres, Chief Executive Officer & DirectorMr. Gregory S. ZanteChief Financial OfficerMs. Marianne ManciniChief Operating OfficerDr. Geoffrey E. Barker Ph.D.Senior Vice President of Pharmaceutical Devel.

NASDAQ : VKTX

Viking Therapeutics

$32.37

1.99+6.55%

At Close 4:00 PM

55.83

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Viking Therapeutics, Inc. (VKTX) stock surged +6.55%, trading at $32.37 on NASDAQ, up from the previous close of $30.38. The stock opened at $30.52, fluctuating between $30.52 and $32.90 in the recent session.

Stock Snapshot

30.38

Prev. Close

3.76B

Market Cap

30.52

Day Low

-7.8

P/E Ratio

-4.15

EPS (TTM)

-0.73

Cash Flow per Share

30.52

Open

116.11M

Number of Shares

32.896

Day High

97.02%

Free Float in %

3.48

Book Value

3.25M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jun 22, 2026	30.52	32.90	30.52	32.37	3.32M
Jun 18, 2026	30.49	31.60	30.16	30.38	3.36M
Jun 17, 2026	30.00	31.27	29.60	30.29	1.88M
Jun 16, 2026	29.50	30.31	29.00	29.65	1.36M
Jun 15, 2026	29.14	29.93	29.04	29.63	1.18M
Jun 12, 2026	28.50	29.28	28.49	28.75	1.16M
Jun 11, 2026	27.60	28.90	27.16	28.61	2.66M
Jun 10, 2026	28.61	29.09	27.61	27.75	2.73M
Jun 09, 2026	29.76	30.10	28.30	29.23	2.25M
Jun 08, 2026	28.75	29.60	28.40	29.24	1.96M
Jun 05, 2026	29.57	29.81	28.04	28.45	2.73M
Jun 04, 2026	29.57	30.18	29.38	29.78	1.72M
Jun 03, 2026	29.39	29.80	29.06	29.33	1.45M
Jun 01, 2026	32.06	32.35	31.27	31.27	1.48M
May 29, 2026	32.25	33.16	31.81	32.74	1.74M
May 28, 2026	31.97	32.44	31.44	32.19	1.46M
May 27, 2026	31.30	32.25	30.75	31.66	1.75M
May 26, 2026	30.92	31.00	30.04	30.80	2.41M
May 22, 2026	30.58	30.92	30.29	30.89	1.22M
May 21, 2026	29.18	30.78	28.80	30.68	2M

Contact Details

San Diego, CA 92121

United States

https://www.vikingtherapeutics.com 858 704 4660

About Company

Viking Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the creation of novel treatments for metabolic and endocrine conditions. The company's leading investigational drug, VK2809, is an orally administered, tissue and receptor-selective agonist of the thyroid hormone receptor beta (TRß). This compound is currently progressing through Phase IIb clinical trials, targeting both non-alcoholic steatohepatitis (NASH) in biopsy-confirmed patients and non-alcoholic fatty liver disease (NAFLD). Viking's pipeline also features VK5211, an oral, non-steroidal selective androgen receptor modulator undergoing Phase II studies for individuals recuperating from non-elective hip fracture surgery. Additionally, VK0612, an oral drug candidate for type 2 diabetes, is poised to enter Phase IIb trials. The firm is also developing VK0214, another orally active, tissue and receptor-selective TRß agonist, specifically aimed at X-linked adrenoleukodystrophy. Founded in 2012, Viking Therapeutics is headquartered in San Diego, California.

Stock Peers

ARGX

26.03+2.97%

argenx SE$903.75 REGN

2.56+0.42%

Regeneron Pharmaceuticals, Inc.$612.50 UTHR

1.70998+0.32%

United Therapeutics Corporation$538.30 MDGL

7.13+1.41%

Madrigal Pharmaceuticals, Inc.$512.88 VRTX

15.16+3.36%

Vertex Pharmaceuticals Incorporated$466.79 KRYS

-4.63-1.33%

Krystal Biotech, Inc.$343.43 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 PRAX

21.08+7.47%

Praxis Precision Medicines, Inc.$303.39 ALNY

8.32+2.99%

Alnylam Pharmaceuticals, Inc.$286.41 LGND

-12.71-4.62%

Ligand Pharmaceuticals Incorporated$262.17

Frequently Asked Questions

What is the current Viking Therapeutics, Inc. (VKTX) stock price?

Viking Therapeutics, Inc. (NASDAQ: VKTX) stock price is $32.37 in the last trading session. During the trading session, VKTX stock reached the peak price of $32.90 while $30.52 was the lowest point it dropped to. The percentage change in VKTX stock occurred in the recent session was 6.55% while the dollar amount for the price change in VKTX stock was $1.99.

VKTX's industry and sector of operation?

The NASDAQ listed VKTX is part of Biotechnology industry that operates in the broader Healthcare sector. Viking Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of VKTX?

Mr. Michael Morneau
Vice President of Fin. & Admin.
Dr. Brian Lian Ph.D.
Pres, Chief Executive Officer & Director
Mr. Gregory S. Zante
Chief Financial Officer
Ms. Marianne Mancini
Chief Operating Officer
Dr. Geoffrey E. Barker Ph.D.
Senior Vice President of Pharmaceutical Devel.

How VKTX did perform over past 52-week?

VKTX's closing price is 40.99% higher than its 52-week low of $22.96 where as its distance from 52-week high of $43.15 is -24.98%.

How many employees does VKTX have?

Number of VKTX employees currently stands at 45.

Link for VKTX official website?

Official Website of VKTX is: https://www.vikingtherapeutics.com

How do I contact VKTX?

VKTX could be contacted at phone 858 704 4660 and can also be accessed through its website. VKTX operates from 9920 Pacific Heights Boulevard, San Diego, CA 92121, United States.

How many shares of VKTX are traded daily?

VKTX stock volume for the day was 3.25M shares. The average number of VKTX shares traded daily for last 3 months was 2.2M.

What is the market cap of VKTX currently?

The market value of VKTX currently stands at $3.76B with its latest stock price at $32.37 and 116.11M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	45
Beta	0.68
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	45
Beta	0.68
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

VKTX Company Profile and Key Details

Viking Therapeutics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Company Overview

Valuation Metrics

Key Takeaways

Price Forecast & Outlook